Proteomic patterns and prediction of glomerulosclerosis and its mechanisms.
暂无分享,去创建一个
Yu Shyr | Richard M Caprioli | Baogang J. Xu | Agnes B Fogo | R. Caprioli | Y. Shyr | Li-jun Ma | N. Brown | Xiubin Liang | A. Fogo | V. Kon | Nancy J Brown | Xueqiong Zhang | Xueqiong Zhang | Baogang J Xu | Xiubin Liang | Li-Jun Ma | Ellen M Donnert | Jeremy D Roberts | Valentina Kon | E. Donnert | Jeremy Roberts | Ellen Donnert
[1] Kermit K. Murray,et al. Laser capture microdissection MALDI for direct analysis of archival tissue. , 2003, Journal of proteome research.
[2] A. Fogo,et al. Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions. , 1991, Kidney international.
[3] Yu Shyr,et al. A training-testing approach to the molecular classification of resected non-small cell lung cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[4] J. Klein,et al. Overview of proteomics. , 2004, Contributions to nephrology.
[5] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[6] Baogang J. Xu,et al. Profiling and imaging proteins in the mouse epididymis by imaging mass spectrometry , 2003, Proteomics.
[7] Baogang J. Xu,et al. Direct analysis of laser capture microdissected cells by MALDI mass spectrometry , 2002, Journal of the American Society for Mass Spectrometry.
[8] Bill C. White,et al. Proteomic patterns of tumour subsets in non-small-cell lung cancer , 2003, The Lancet.
[9] D. Vaughan,et al. Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. , 1995, The Journal of clinical investigation.
[10] C. Marcantoni,et al. Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1. , 2000, Kidney international.
[11] H. Kleinman,et al. Thymosin β4 enhances endothelial cell differentiation and angiogenesis , 2004, Angiogenesis.
[12] E. Dougherty,et al. Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.
[13] M. Madaio,et al. Isolation, culture, and characterization of endothelial cells from mouse glomeruli. , 2004, Kidney international.
[14] E. Feener,et al. MEK1,2 response element mediates angiotensin II-stimulated plasminogen activator inhibitor-1 promoter activation. , 2004, Blood.
[15] H. Mannherz,et al. Nuclear localisation of the G-actin sequestering peptide thymosin β4 , 2004, Journal of Cell Science.
[16] D. Palmer-Toy,et al. Direct acquisition of matrix-assisted laser Desorption/Ionization time-of-flight mass spectra from laser capture microdissected tissues , 2000, Clinical chemistry.
[17] Yu Shyr,et al. Weighted Flexible Compound Covariate Method for Classifying Microarray Data , 2003 .
[18] M. Stoeckli,et al. Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues , 2001, Nature Medicine.
[19] J. Yates,et al. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database , 1994, Journal of the American Society for Mass Spectrometry.
[20] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[21] A. Fogo,et al. Role of angiotensin II in glomerular injury. , 2001, Seminars in nephrology.
[22] Nir Friedman,et al. Scoring Genes for Relevance , 2000 .
[23] J. Tukey. Tightening the clinical trial. , 1993, Controlled clinical trials.
[24] D. Safer,et al. Isolation of a 5-kilodalton actin-sequestering peptide from human blood platelets. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[25] D. Kerjaschki,et al. Unexplained nephrotic-range proteinuria in a 38-year-old man: a case of "no change disease". , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[26] Nir Friedman,et al. Practical approaches to analyzing results of microarray experiments. , 2002, American journal of respiratory cell and molecular biology.
[27] Werner Dubitzky,et al. A Practical Approach to Microarray Data Analysis , 2003, Springer US.
[28] M. Czyz,et al. Thymosin beta 4 induces the synthesis of plasminogen activator inhibitor 1 in cultured endothelial cells and increases its extracellular expression. , 2004, Blood.
[29] M. Kretzler. Role of podocytes in focal sclerosis: defining the point of no return. , 2005, Journal of the American Society of Nephrology : JASN.
[30] A. Otto,et al. Thymosin β4 is released from human blood platelets and attached by factor XIIIa (transglutaminase) to fibrin and collagen , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] A. Fogo. Glomerular hypertension, abnormal glomerular growth, and progression of renal diseases. , 2000, Kidney international. Supplement.
[32] A. Fogo,et al. Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. , 1990, Kidney international.
[33] D. Srivastava,et al. Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair , 2004, Nature.
[34] L. Liotta,et al. Laser capture microdissection. , 2006, Methods in molecular biology.
[35] A. Eddy. Plasminogen activator inhibitor-1 and the kidney. , 2002, American journal of physiology. Renal physiology.